Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Gynecol Obstet Invest ; 83(2): 133-139, 2018.
Article in English | MEDLINE | ID: mdl-28511185

ABSTRACT

Myeloperoxidase (MPO) is a proinflammatory enzyme and a marker for neutrophil activation and oxidative stress. Since oxidative stress and inflammation are linked to the pathogenesis of endometriosis, we hypothesized that the total, active, and specific (active/total) MPO levels were significantly different in plasma of women with and without endometriosis. Samples were selected from our biobank from women with endometriosis (n = 212) and controls without endometriosis (n = 121) across the menstrual cycle. Total MPO plasma levels were measured by immunoassay and MPO activity by enzymatic assay. Total and active MPO levels did not differ significantly among endometriosis cases and controls, whereas the specific MPO activity was significantly lower in women with endometriosis than that in controls (p = 0.0159). After the subdivision of control patients into women with a normal pelvis and women with other benign gynecological disorders, a significant difference was observed only between women with endometriosis and women with other benign gynecological disorders (p = 0.0266). In conclusion, systemic MPO levels may not be suited as a single biomarker for endometriosis. Our data support the involvement of MPO in other gynecological disorders but do not provide any evidence for an association with endometriosis.


Subject(s)
Endometriosis/enzymology , Genital Diseases, Female/enzymology , Peroxidase/blood , Adult , Biomarkers/blood , Endometriosis/blood , Enzyme-Linked Immunosorbent Assay , Female , Genital Diseases, Female/blood , Humans
2.
Reprod Toxicol ; 44: 63-72, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24316331

ABSTRACT

We studied the effects of neonatal exposure to diethylstilbestrol (DES) on pubertal timing in female rats. We examined associated neuroendocrine changes and effects of prenatal food restriction. Age at vaginal opening was advanced after exposure to 10 µg/kg/d of DES and delayed after 1 µg/kg/d (subcutaneous injections). Using this lower dose, pulsatile GnRH secretion was slower at 25 days of age. Both doses reduced KiSS1 mRNA levels at 15 days of age. Using functional Kisspeptin promoter assay, 1 or 10 µM DES reduced or increased KISS1 transcription, respectively. Leptin stimulatory effect on GnRH secretion in vitro (15 days of age) was reduced after prenatal food restriction and neonatal DES exposure (higher dose), both effects being cumulative. Thus, alterations in pubertal timing by DES neonatally are not unequivocally toward precocity, the level of exposure being critical. We provide evidence of neuroendocrine disruption and interaction with prenatal food availability.


Subject(s)
Diethylstilbestrol/toxicity , Endocrine Disruptors/toxicity , Estrogens, Non-Steroidal/toxicity , Gonadotropin-Releasing Hormone/metabolism , Kisspeptins/genetics , Sexual Maturation/drug effects , Animals , Animals, Newborn , Cell Line , Estrous Cycle/drug effects , Female , Food Deprivation , Hypothalamus/drug effects , Hypothalamus/metabolism , Leptin/blood , Mice , Pregnancy , Prenatal Nutritional Physiological Phenomena , RNA, Messenger/metabolism , Rats, Wistar , Vagina/drug effects , Vagina/growth & development
SELECTION OF CITATIONS
SEARCH DETAIL
...